The European Commission has granted EU marketing authorisation in 28 countries for Vargatef (nintedanib), from Boehringer, in combination with docetaxel...
This is a prospective randomized phase II clinical trial where patients who are receiving enzalutamide in the pre-chemotherapy space are...
Randomised controlled trial (RCT) data suggest that docetaxel (formerly Taxotere from Sanofi and now generic) improves overall survival and time...
BMS has announced that Opdivo (nivolumab) is the first PD-1 inhibitor to demonstrate superior overall survival versus standard of care...